Histogenesis of the acquired cystic kidney disease: An immunohistochemical study

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 3, 2006, Pages 348-352

  De Oliveira Costa, Maria Zélia ^a   Bacchi, Carlos Eduardo ^b   Franco, Marcello ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Acquired cystic kidney disease; Histogenesis; Immunohistochemistry; Lectins

Indexed keywords

AGGLUTININ; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; PARAFFIN; TAMM HORSFALL GLYCOPROTEIN; VIMENTIN;

ARTICLE; BOWMAN MEMBRANE; CONTROLLED STUDY; DISEASE MARKER; DOLICHOS; HISTOGENESIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY DISTAL TUBULE; KIDNEY PARENCHYMA; KIDNEY POLYCYSTIC DISEASE; KIDNEY PROXIMAL TUBULE; PEANUT; PRIORITY JOURNAL; STAINING; ULEX EUROPAEUS; URINE;

BIOLOGICAL MARKERS; CYSTS; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES, CYSTIC;

EID: 33748264900     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/00129039-200609000-00015     Document Type: Article

References (57)

1. Gardner KD Jr. Cystic kidneys. Kidney Int. 1988;33:610-621.
2. Gehrig JJ Jr, Gottheiner TI, Swenson RS. Acquired cystic disease of the end-stage kidney. Am J Clin Pathol. 1985;79:609-619.
3. Dunnill MS, Millard PR, Oliver D. Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol. 1977;30:868-877.
4. Narasimhan N, Golper TA, Wolfson M, et al. Clinical characteristics and diagnostic considerations in acquired renal cystic disease. Kidney Int. 1986;30:748-752.
5. Jennette JC, Olson JL, Schwartz MM, et al. End-stage renal disease: acquired renal cystic disease. In: Heptinstall's pathology of the kidney, 5th ed. Philadelphia: Lippincott-Raven, 1998:1371-1408.
6. Ratcliffe J, Dunnill MS, Oliver DO. Clinical importance of acquired cystic disease of the kidney in patients undergoing dialysis. Br Med J. 1983;287:1855-1858.
7. Miller LR, Soffer O, Nassas VH, et al. Acquired renal cystic disease in end-stage renal disease: an autopsy study of 155 cases. Am J Nephrol. 1989;9:322-328.
8. Basile JJ, McCullough DL, Harrison LH, et al. End-stage renal disease associated with acquired cystic disease and neoplasia. J Urol. 1988;140:938-943.
9. Grantham JJ. Acquired cystic kidney disease. Kidney Int. 1991;40:143-152.
10. Mickisch O, Bommer J, Bachmann S, et al. Multicystic transformation of kidneys in chronic renal failure. Nephron. 1984;38:93-99.
11. Ishikawa I, Onouchi Z, Saito Y, et al. Sex differences in acquired cystic disease of the kidney on long-term dialysis. Nephron. 1985;39:336-340.
12. Sant GR, Ucci AA Jr. Acquired renal cystic disease and adenocarcinoma following renal transplantation: a current urologic perspective. Urol Int. 1998;60:108-112.
13. Chandhoke PS, Torrence RJ, Clayman RV, et al. Acquired cystic disease of the kidney: a management dilemma. J Urol. 1992;147:969-974.
14. Ishikawa I, Saito Y, Asaka M, et al. Twenty-year follow-up of acquired renal cystic disease. Clin Nephrol. 2003;59:153-159.
15. Grantham JJ. Pathogenesis of renal cyst expansion: opportunities for therapy. Am J Kidney Dis. 1994;23:210-218.
16. Bellinghieri G, Magaudda L, Santoro D, et al. Extracellular matrix abnormality may be responsible for cyst development. Contrib Nephrol. 1977;122:38-44.
17. Cohen EP, Elliott WC Jr. The role of ischemia in acquired cystic kidney disease. Am J Kidney Dis. 1990;15:55-60.
18. Ishikawa I, Horiguchi T, Shikura N. Lectin peroxidase conjugate reactivity in acquired cystic disease of the kidney. Nephron. 1989;51:211-214.
19. Therezo ALS, Bacchi CE, Franco MF. Histogenesis of the cysts in the autosomal dominant polycystic kidney disease: an immunohistochemical study. Appl Immunohistochem Mol Meth. 1998;6:219-223.
20. Faraggiana T, Bernstein J, Strauss L, et al. Use of lectins in the study of histogenesis of renal cysts. Lab Invest. 1985;53:575-579.
21. Deck MA, Verani R, Silva FG, et al. Histogenesis of renal cysts in end-stage renal disease (acquired cystic kidney disease): an immunohistochemical and lectin study. Am J Surg Pathol. 1988;1:391-406.
22. Verani RR, Silva GF. Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: a histochemical study. Mod Pathol. 1988;1:457-463.
23. D'Agati V, Trudel M. Lectin characterization of cystogenesis in the SBM transgenic model of polycystic kidney disease. J Am Soc Nephrol. 1992;3:975-983.
24. Kovacs J, Zilahy M, Gomba S. Morphology of cystic renal lesions. Lectin and immuno-histochemical study. Acta Chir Hung. 1997;36:176-178.
25. Damjanov I. Lectin cytochemistry and histochemistry. Lab Invest. 1987;57:5-20.
26. Truong LD, Phung VT, Yoshikawa Y, et al. Glycoconjugates in normal human kidney: a histochemical study using 13 biotylated lectins. Histochemistry. 1988;90:51-60.
27. Faraggiana T, Malchiodi F, Prado A, et al. Lectin-peroxidase conjugate reactivity in normal human kidney. J Histochem Cytochem. 1982;30:451-458.
28. Pereira MEA, Kabat EA. Specificity of purified hemagglutinin (Lectin) from Lotus tetragonolobus. Biochemistry. 1974;13:3184-3192.
29. Hennigar RA, Schulte BA, Spicer SS. Heterogeneous distribution of glycoconjugates in human kidney tubules. Anat Rec. 1985;211:376-390.
30. Stoward PJ, Spicer SS, Miller RL. Histochemical reactivity of peanut lectin-horseradish. J Histochem Cytochem. 1980;28:979-990.
31. Makoto W, Muramatsu T, Shirane H, et al. Discrete distribution of binding sites for Dolichos biflorus agglutinin (DBA) and for peanut agglutinin (PNA) in mouse organ tissues. J Histochem Cytochem. 1981;29:779-790.
32. Reisner Y, Gachelin G, Dubois P, et al. Interaction of peanut agglutinin, a lectin specific for nonreducing terminal d-galactosyl residues, with embryonal carcinoma cells. Dev Biol. 1977;61:20-27.
33. Murata F, Tsuyama S, Suzuki S, et al. Distribution of glycoconjugates in the kidney studied by use of labeled lectins. J Histochem Cytochem. 1983;31:139-144.
34. Kikuchi Y. Lectin and immunohistochemical studies on acquired cystic kidney and associated renal cell carcinoma. Acta Pathol Jpn. 1989;39:373-380.
35. Holthöfer H. Lectin binding sites in kidney: a comparative study of 14 animal species. J Histochem Cytochem. 1983;31:531-537.
36. Holthöfer H, Virtanen I, Pettersson E, et al. Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest. 1981;45:391.
37. Pereira MEA, Kisailus EC, Gruezo F, et al. Immunochemical studies on the combining site of the blood group H-specific lectin 1 from Ulex europaeus seeds. Arch Biochem Biophys. 1978;185:108-115.
38. Oosterwijk E, Van Muijen GNP, Oosterwijk-Wakka JC, et al. Expression of intermediate-sized filaments in developing and adult human kidney and in renal cell carcinoma. J Histochem Cytochem. 1990;38:385-392.
39. Gröne HJ, Weber K, Gröne E, et al. Co-expression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol. 1987;129:1-8.
40. Waldherr R, Schwechheimer K. Co-expression of cytokeratin and vimentin intermediate-sized filaments in renal cell carcinomas. Virch Arch A Pathol Anat Histopathol. 1985;408:15-27.
41. Holthöfer H, Miettinen A, Lehto VP, et al. Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest. 1984;50:552-559.
42. Fleming S, Symes CE. The distribution of cytokeratin antigens in the kidney and in renal tumours. Histopathology. 1987;11:157-170.
43. Moll R, Hage C, Thoenes W. Expression in intermediate filament proteins in fetal and adult human kidney: modulations of intermediate filament patterns during development and in damaged tissue. Lab Invest. 1991;65:74-86.
44. Holm-Nielson P, Pallesen G. Expression of segment-specific antigens in the human nephron and in renal epithelial tumors. APMIS Suppl. 1988;4:48-55.
45. Hiasa Y, Kitamura M, Nakaoka S, et al. Antigen immunohistochemistry of renal cell adenomas in autopsy cases: relevance to histogenesis. Oncology. 1995;52:97-105.
46. Khurana KK, Truong LD, Verani RR. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma. Mod Pathol. 1998;11:339-346.
47. Sheibani K, Battifora H, Burke JS, et al. Leu-M1 antigen in human neoplasms: an immunohistologic study of 400 cases. Am J Surg Pathol. 1986;10:227-236.
48. Sikri KL, Foster CL, MacHugh N, et al. Localization of Tamm-Horsfall glycoprotein in the human kidney using immuno-fluorescence and immuno-electron microscopical techniques. J Anat. 1981;132:597-605.
49. Wallace AC, Nairn RC. Renal tubular antigens in kidney tumors. Cancer. 1972;29:977-981.
50. Schenk EA, Schwartz RH, Lewis RA. Tamm-Horsfall mucoprotein. I. Localization in the kidney. Lab Invest. 1971;25:92-95.
51. Howie AJ. Epithelial membrane antigen in normal and proteinuric glomeruli and in damaged proximal tubules. J Pathol. 1986;148:55-60.
52. Susuki M, Nikaido T, Ikegami M, et al. Renal adenoma: clinicopathological and histochemical studies. Acta Pathol Jpn. 1989;39:731-736.
53. Sloane JP, Ormerod MG. Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathology. Cancer. 1981;47:1786-1795.
54. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577-580.
55. Hsu SM, Raine L. Versatility of biotin-labeled lectins and avidin-biotin-peroxidase complex for localization of carbohydrate in tissue sections. J Histochem Cytochem. 1982;30:157-161.
56. Hsu M, Raine L. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem. 1981;29:1349-1353.
57. Debray H, Decout D, Strecker G, et al. Specificity of twelve lectins towards oligosaccharides and glycopeptides related to N-glycosylproteins. Eur J Biochem. 1981;117:41-55.